BRPI0718131A2 - (S) - (+) - 2- (2-Chlorophenyl) -HYDROXY-ETHYL CARBAMATE CRYSTAL - Google Patents

(S) - (+) - 2- (2-Chlorophenyl) -HYDROXY-ETHYL CARBAMATE CRYSTAL

Info

Publication number
BRPI0718131A2
BRPI0718131A2 BRPI0718131-0A2A BRPI0718131A BRPI0718131A2 BR PI0718131 A2 BRPI0718131 A2 BR PI0718131A2 BR PI0718131 A BRPI0718131 A BR PI0718131A BR PI0718131 A2 BRPI0718131 A2 BR PI0718131A2
Authority
BR
Brazil
Prior art keywords
chlorophenyl
hydroxy
crystal
ethyl carbamate
carbamate
Prior art date
Application number
BRPI0718131-0A2A
Other languages
Portuguese (pt)
Inventor
Matthew Peterson
Original Assignee
Transform Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transform Pharmaceuticals Inc filed Critical Transform Pharmaceuticals Inc
Publication of BRPI0718131A2 publication Critical patent/BRPI0718131A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
BRPI0718131-0A2A 2006-10-06 2007-10-05 (S) - (+) - 2- (2-Chlorophenyl) -HYDROXY-ETHYL CARBAMATE CRYSTAL BRPI0718131A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82839206P 2006-10-06 2006-10-06
PCT/US2007/021502 WO2008045391A2 (en) 2006-10-06 2007-10-05 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate

Publications (1)

Publication Number Publication Date
BRPI0718131A2 true BRPI0718131A2 (en) 2013-11-05

Family

ID=39283405

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0718131-0A2A BRPI0718131A2 (en) 2006-10-06 2007-10-05 (S) - (+) - 2- (2-Chlorophenyl) -HYDROXY-ETHYL CARBAMATE CRYSTAL

Country Status (19)

Country Link
US (1) US7632963B2 (en)
EP (1) EP2076258A4 (en)
JP (1) JP2010505856A (en)
KR (1) KR20090076958A (en)
CN (1) CN101657195A (en)
AU (1) AU2007307029A1 (en)
BR (1) BRPI0718131A2 (en)
CA (1) CA2665573A1 (en)
CO (1) CO6180504A2 (en)
CR (1) CR10764A (en)
EA (1) EA200970355A1 (en)
GT (1) GT200900076A (en)
IL (1) IL198016A0 (en)
MX (1) MX2009003755A (en)
NI (1) NI200900050A (en)
NO (1) NO20091771L (en)
SV (1) SV2009003211A (en)
WO (1) WO2008045391A2 (en)
ZA (1) ZA200903095B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
KR101795562B1 (en) * 2011-12-27 2017-11-08 (주)바이오팜솔루션즈 Phenyl carbamate compounds for use in preventing or treating stroke
CA3227793A1 (en) * 2021-08-05 2023-02-09 Yong Moon Choi Phenyl carbamate crystalline form and method for preparing same
KR102399807B1 (en) * 2021-08-05 2022-05-20 (주)바이오팜솔루션즈 Phenylcarbamate crystalline form and method for manufacturing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
KR100602617B1 (en) * 1999-09-10 2006-07-20 다이니혼 잉키 가가쿠 고교 가부시키가이샤 Quinolinone derivative preparations and process for producing the same
RS51055B (en) * 2001-02-27 2010-10-31 Ortho-Mcneil Pharmaceutical Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
EE05381B1 (en) * 2001-12-21 2011-02-15 Ortho-McNeil�Pharmaceutical,�Inc. Process for the Preparation of 2- (Substituted-Phenyl) -2-H-Diacarbamates, Intermediate Compounds and Morpho-Formations of Carbamates
BRPI0413595B8 (en) 2003-08-18 2021-05-25 H Lundbeck As malonate salt, pharmaceutical composition, use of a malonate salt, and method of manufacturing a compound
ATE464044T1 (en) * 2004-09-16 2010-04-15 Janssen Pharmaceutica Nv USE OF 2-PHENYL-1,2-ETHANEDIOL (DI)CARBAMATES FOR THE TREATMENT OF EPILEPTOGENesis
US20070021500A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods for neuroprotection

Also Published As

Publication number Publication date
AU2007307029A1 (en) 2008-04-17
CR10764A (en) 2009-09-14
EP2076258A4 (en) 2011-09-28
NI200900050A (en) 2010-02-01
US20080085930A1 (en) 2008-04-10
GT200900076A (en) 2010-05-18
US7632963B2 (en) 2009-12-15
KR20090076958A (en) 2009-07-13
EP2076258A2 (en) 2009-07-08
CO6180504A2 (en) 2010-07-19
JP2010505856A (en) 2010-02-25
SV2009003211A (en) 2009-11-24
EA200970355A1 (en) 2009-12-30
MX2009003755A (en) 2009-07-10
WO2008045391A2 (en) 2008-04-17
CA2665573A1 (en) 2008-04-17
WO2008045391A3 (en) 2008-06-12
NO20091771L (en) 2009-05-05
IL198016A0 (en) 2009-12-24
CN101657195A (en) 2010-02-24
ZA200903095B (en) 2010-07-28

Similar Documents

Publication Publication Date Title
CY2016029I2 (en) SUBTILYSIN KEKIN-TYPE 9 (PCSK9) ANTIGEN-BINDING PROTEIN-CONVERTING PROTEIN
DE502006003629D1 (en) LASSTABLE GROUP GEAR
DE602005001664D1 (en) Optical rangefinder
DE602005005030D1 (en) STAGE-FREE BELT GEAR
FI20055630A0 (en) face pack
DE502005005664D1 (en) Chronograph
DE112006003808A5 (en) Wrist strap
DE502005004534D1 (en) comber
BRPI0718131A2 (en) (S) - (+) - 2- (2-Chlorophenyl) -HYDROXY-ETHYL CARBAMATE CRYSTAL
DE112007002678A5 (en) watch case
DE502005003827D1 (en) gear
DE112005001381T5 (en) Gear system
BRPI0717824A2 (en) (S) - (+) - 2- (2-CHLOROPHYL) -2-HYDROXY-ETHYL CARBAMATE CRYSTAL
ITMI20052367A1 (en) crystallizer
DK1723278T3 (en) Multiaxial complex
FR2877833B1 (en) CORRECTEUR OF LORDOSES
FR2908664B3 (en) SWIMMING GOGGLES
FI20040753A0 (en) Protective Gear
ES1064213Y (en) SWIMMING GOGGLES
ES1062437Y (en) SWIMMING GOGGLES
ITNA20060014U1 (en) ALETTINE BRACELETS FOR SWIMMING
FI20041336A0 (en) Gear
ES1061606Y (en) SWIMMING GOGGLES
ES1061605Y (en) SWIMMING GOGGLES
ES1060241Y (en) SWIMMING GOGGLES

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A, 6A E 7A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.